• 1. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to (S)-1-N-Boc-piperidine-2-carboxamide (CAS No. 78058-41-0)

(S)-1-N-Boc-piperidine-2-carboxamide (CAS No. 78058-41-0) is a chiral compound that has garnered significant attention in the fields of organic synthesis, medicinal chemistry, and pharmaceutical research. This compound is a derivative of piperidine, a six-membered nitrogen-containing ring, with a tert-butyloxycarbonyl (Boc) protecting group attached to the nitrogen atom and a carboxamide functional group at the 2-position. The Boc group is widely used in peptide synthesis to protect the amino group from unwanted reactions, ensuring that the desired chemical transformations occur selectively.

The chiral nature of (S)-1-N-Boc-piperidine-2-carboxamide makes it particularly valuable in the synthesis of enantiomerically pure compounds. Enantiomeric purity is crucial in pharmaceutical development, as different enantiomers of a drug can exhibit distinct biological activities, including efficacy and toxicity. The ability to synthesize and isolate specific enantiomers is therefore essential for optimizing the therapeutic potential of new drugs.

Recent studies have highlighted the importance of (S)-1-N-Boc-piperidine-2-carboxamide in various synthetic routes. For instance, a 2023 study published in the Journal of Organic Chemistry described an efficient and scalable method for synthesizing this compound using asymmetric catalysis. The method involves the use of a chiral catalyst to achieve high enantioselectivity, yielding (S)-1-N-Boc-piperidine-2-carboxamide with greater than 99% ee (enantiomeric excess). This advancement has significant implications for the large-scale production of this compound for both research and industrial applications.

In the context of medicinal chemistry, (S)-1-N-Boc-piperidine-2-carboxamide has been explored as a building block for the synthesis of novel bioactive molecules. A notable example is its use in the development of inhibitors for protein-protein interactions (PPIs), which are increasingly recognized as important therapeutic targets in various diseases, including cancer and neurodegenerative disorders. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported the synthesis of a series of PPI inhibitors based on the (S)-1-N-Boc-piperidine-2-carboxamide scaffold. These inhibitors demonstrated potent activity against specific PPIs involved in cell signaling pathways, suggesting their potential as lead compounds for drug discovery.

The stability and reactivity of (S)-1-N-Boc-piperidine-2-carboxamide have also been extensively studied. The Boc protecting group can be selectively removed under mild acidic conditions, allowing for further functionalization of the piperidine ring. This property makes it an attractive intermediate in multi-step synthetic sequences where controlled deprotection is required. Additionally, the carboxamide group can participate in various chemical reactions, such as amide bond formation and coupling reactions with other functional groups.

In clinical research, compounds derived from (S)-1-N-Boc-piperidine-2-carboxamide have shown promise in preclinical studies. For example, a 2023 study published in Clinical Cancer Research evaluated a novel small molecule inhibitor derived from this scaffold for its anticancer properties. The inhibitor selectively targeted a specific protein involved in tumor growth and metastasis, demonstrating significant antiproliferative effects in both cell culture and animal models. These findings underscore the potential therapeutic applications of compounds derived from (S)-1-N-Boc-piperidine-2-carboxamide.

The environmental and safety aspects of (S)-1-N-Boc-piperidine-2-carboxamide have also been considered. While it is not classified as a hazardous material or controlled substance, proper handling and storage are recommended to ensure safety and maintain its chemical integrity. The compound should be stored under dry conditions at room temperature and protected from light to prevent degradation.

In conclusion, (S)-1-N-Boc-piperidine-2-carboxamide (CAS No. 78058-41-0) is a versatile and valuable compound with wide-ranging applications in organic synthesis, medicinal chemistry, and pharmaceutical research. Its chiral nature, stability under various reaction conditions, and potential for further functionalization make it an important intermediate in the development of novel bioactive molecules and therapeutic agents. Ongoing research continues to uncover new uses and optimizations for this compound, solidifying its position as a key player in modern chemical and pharmaceutical science.

• 848488-91-5((R)-1-N-Boc-Pipecolamide)
• 105443-94-5(tert-butyl (2S)-2-carbamoylazetidine-1-carboxylate)
• 54503-10-5(tert-Butyl 2-carbamoylpyrrolidine-1-carboxylate)
• 70138-72-6(1-Boc-D-prolinamide)
• 388077-74-5((+/-)-1-N-boc-Piperidine-2-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)